Pfizer (NYSE: PFE) issued its quarterly earnings data on Tuesday. The company reported $0.47 earnings per share for the quarter, beating the analysts? consensus estimate of $0.44 by $0.03. The company had revenue of $15.10 billion for the quarter, compared to the consensus estimate of $14.40 billion. During the same quarter last year, the company posted $0.50 earnings per share. Pfizer?s revenue was down 6.6% compared to the same quarter last year. Pfizer updated its FY13 guidance to $2.20-2.30 EPS.
A number of analysts have recently weighed in on PFE shares. Analysts at BMO Capital Markets raised their price target on shares of Pfizer to $30.00 in a research note to investors on Monday. They now have an ?outperform? rating on the stock. On a related note, analysts at Barclays Capital raised their price target on shares of Pfizer from $24.00 to $25.00 in a research note to investors on Tuesday, January 22nd. They now have an ?equal weight? rating on the stock. Finally, analysts at JPMorgan Chase reiterated an ?overweight? rating on shares of Pfizer in a research note to investors on Tuesday, January 22nd. They now have a $29.00 price target on the stock.
Sixteen research analysts have rated the stock with a buy rating, three have issued an overweight rating, and five have assigned a hold rating to the company?s stock. Pfizer has an average rating of ?overweight? and an average price target of $28.63.
Shares of Pfizer (PFE) traded up 2.35% during mid-day trading on Tuesday, hitting $27.47. Pfizer (PFE) has a one year low of $20.75 and a one year high of $27.30. The stock?s 50-day moving average is currently $25.94. The company has a market cap of $202.2 billion and a P/E ratio of 21.02.
The company also recently declared a quarterly dividend, which is scheduled for Tuesday, March 5th. Investors of record on Friday, February 1st will be given a dividend of $0.24 per share. This represents a $0.96 dividend on an annualized basis and a yield of 3.56%. The ex-dividend date of this dividend is Wednesday, January 30th. This is an increase from Pfizer?s previous quarterly dividend of $0.22.
Pfizer Inc. (Pfizer) is a research-based, global biopharmaceutical company. The Company applies science and its global resources to improve health and well-being at every stage of life.